1-20 of 96
Brian T. Hill, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with Relapsed/Refractory Double Expressor B Cell Lymphoma As Defined By Multicenter Pathology Review Treated with Ibrutinib Monotherapy

Daniel J. Landsburg, MD, Mitchell E. Hughes, PharmD, Alexa Koike, David A. Bond, MD, Kami J. Maddocks, MD, Ling Guo, MD, Allison M. Winter, MD, Brian T. Hill, MD PhD, Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD, Agata M. Bogusz, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 455.
https://doi.org/10.1182/blood-2018-99-117514
Published: 2018
Journal Articles

Intensive Induction Regimens after Deferring Initial Therapy Are Not Associated with Improved Progression-Free or Overall Survival in Patients with Mantle Cell Lymphoma (MCL)

Krithika Shanmugasundaram, MD, Subir Goyal, MPH, MBBS, Jeffrey M. Switchenko, PhD MS, Oscar Calzada, BS, Michael C Churnetski, BS, Bhaskar Kolla, MBBS, Veronika Bachanova, MD PhD, James Nathan Gerson, MD, Stefan Klaus Barta, MD MRCP, MS, Max J. Gordon, MD, Alexey V Danilov, MD PhD, Natalie S Grover, MD, Stephanie Mathews, MD, Madelyn Burkart, MD, Reem Karmali, MD, Yazeed Sawalha, MD, Brian T. Hill, MD PhD, Nilanjan Ghosh, MD PhD, Steven I Park, MD, Narendranath Epperla, MD MS, David A. Bond, MD, Talha Badar, MD, Kristie A. Blum, MD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Mary Malacek, MD, Brad S. Kahl, MD, Christopher R Flowers, MD MS, Jonathon B. Cohen, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4153.
https://doi.org/10.1182/blood-2018-99-117547
Published: 2018
Journal Articles

Outcomes of Patients with Limited-Stage Aggressive Large B-Cell Lymphoma with MYC Rearrangement with and without BCL2 and/or BCL6 Rearrangements: A Retrospective Analysis from 15 US Academic Centers

Shalin K. Kothari, MD, Shaoying Li, MD, L. Jeffrey Medeiros, MD, Emily C. Ayers, MD, Daniel J. Landsburg, MD, David A. Bond, MD, Kami J. Maddocks, MD, Anshu Giri, MD, Brian T. Hess, MD, Luu Q. Pham, Ranjana Advani, MD, Yang Liu, MD, Stefan Klaus Barta, MDMRCP,MS, Julie M. Vose, MDMBA, Michael C. Churnetski, BS, Jonathon B. Cohen, MDMS, Madelyn Burkart, MD, Reem Karmali, MD, Joanna Zurko, MD, Amitkumar Mehta, MD, Adam J Olszewski, MD, Sarah S Lee, MD, Brian T. Hill, MD PhD, Timothy F. Burns, MD, Frederick Lansigan, MD, Emma Rabinovich, MD, David Peace, MD, Adrienne Groman, MS, Kris Attwood, PhD MS, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 451.
https://doi.org/10.1182/blood-2018-99-111530
Published: 2018
Journal Articles

Risk of Post-Transplant Lymphoproliferative Disorders (PTLD) in Solid Organ Transplantation Patients with EBV Viremia

Yazeed Sawalha, MD, John McMichael, PhD, Lisa Rybicki, MS, Tamara A. Sussman, MD, Alex V. Mejia Garcia, MD, Robert M. Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 4202.
https://doi.org/10.1182/blood-2018-99-114686
Published: 2018
Journal Articles

Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy

Emily C. Ayers, MD, Shaoying Li, MD, Jeffrey Medeiros, MD, David A. Bond, MD, Kami J. Maddocks, MD, Pallawi Torka, MD, Angel Mier Hicks, MD, Madeira Curry, Nina D. Wagner-Johnston, MD, Reem Karmali, MD, Amir Behdad, MD, Bita Fakhri, MDMPH, Brad S Kahl, MD, Michael C Churnetski, BS, Jonathon B. Cohen, MDMS, Nishitha Reddy, MD, Dipenkumar Modi, MD, Radhakrishnan Ramchandren, MD, Christina Howlett, PharmD, BCOP, Lori A. Leslie, MD, Samuel Cytryn, Catherine Diefenbach, MD, Rawan Faramand, MD, Julio C. Chavez, MD, Adam J Olszewski, MD, Yang Liu, MD, Stefan Klaus Barta, MDMRCP,MS, Dhruvika Mukhija, MD, Brian T. Hill, MD PhD, Helen Ma, MD, Jennifer E Amengual, MD, Sunita Nathan, MD, Sarit Assouline, Victor M. Orellana-Noia, MD, Craig A. Portell, MD, Ashwin Chandar, MD, Kevin A. David, MD, Anshu Giri, MD, Brian T. Hess, MD, Daniel J. Landsburg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 453.
https://doi.org/10.1182/blood-2018-99-115527
Published: 2018
Journal Articles

Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall Survival

Allison M. Winter, MD, Loretta J. Nastoupil, MD, Melody R. Becnel, MD, James R. Cerhan, MD PhD, Thomas M. Habermann, MD, Brian K. Link, MD, Matthew J. Maurer, MS, Bita Fakhri, MD MPH, Prathima Reddy, MD, Stephen D. Smith, MD, Dhruvika Mukhija, MD, Deepa Jagadeesh, MD MPH, Amrita Desai, MD, Juan Pablo Alderuccio, MD, Izidore S. Lossos, MD, Pooja Mehra, MD, Craig A. Portell, MD, Christopher R. D'Angelo, MD, Vaishalee P. Kenkre, MD, Max L. Goldman, MD, Oscar Calzada, BS, Jonathon B. Cohen, MD MS, Mohammad Junaid Hussain, MD, Nilanjan Ghosh, MD PhD, Yang Liu, MD, Stefan Klaus Barta, MD MRCP, MS, Paolo F Caimi, MD, Adam Kittai, MD, Alexey V Danilov, MD PhD, Timothy Tiutan, MD, Peter Martin, FRCPC, MD MS, Nathalie Danielson, MSN, RN, ACNP-BC, Manali Kamdar, MD, Abhigna Kodali, MD, Andrew M. Evens, DO, MSc, Brad S Kahl, MD, Brian T. Hill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4146.
https://doi.org/10.1182/blood-2018-99-118530
Published: 2018
Journal Articles

Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings

Lindsey E. Roeker, MD, Christopher P. Fox, MD PhD, Toby A. Eyre, John N. Allan, MD, Stephen J. Schuster, MD, Chadi Nabhan, MD, Brian T. Hill, MD PhD, Nirav N Shah, MD, Frederick Lansigan, MD, Maryam Yazdy, MD, Nicole Lamanna, MD, Bruce Cheson, MD, Arun K Singavi, MD, Catherine C. Coombs, MD, Paul Barr, MD, Alan P Skarbnik, MD, Mazyar Shadman, MD MPH, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Allison M. Winter, MD, Joanna Rhodes, MD, Colleen Dorsey, BSN, RN, Hannah Morse, BSN, John M. Pagel, MD PhD, Annalynn M Williams, MS, Ryan Jacobs, MD, Andre Goy, MD, Sivraj Muralikrishnan, MD, Laurie Pearson, MD, Andrea Sitlinger, MD, Neil Bailey, MSc, Anna Schuh, MD PhD, Danielle M. Brander, MD, Amy A Kirkwood, MSc, Anthony R Mato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4410.
https://doi.org/10.1182/blood-2018-99-118159
Published: 2018
Journal Articles

Factors That Influence Treatment Decision-Making: Perspectives of 1147 Chronic Lymphocytic Leukemia (CLL) Patients in the United States

Brian Koffman, MDM, DCFP, DABFM, MS Ed, Betsy Dennison, MS, RN, Kaitlin Kennard, RN, BSN, John C. Byrd, MD, Richard R. Furman, MD, John M. Pagel, MD PhD, Matthew S Davids, Chadi Nabhan, MD, Neil E. Kay, MD, Tanya Siddiqi, MD, Danielle M. Brander, MD, William G. Wierda, MD PhD, Deborah M. Stephens, Brian T. Hill, MD PhD, Javier Pinilla Ibarz, MD, Bruce Cheson, MD, Steven T Rosen, Farrukh T. Awan, MD MS, Michael Y. Choi, MD, Thomas E Henry, MBA, RPh, CPh, Lindsey E. Roeker, MD, Anthony R. Mato, MD MSCE
Journal: Blood
Blood (2018) 132 (Supplement 1): 4414.
https://doi.org/10.1182/blood-2018-99-112971
Published: 2018
Journal Articles

Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non-GCB Subtypes: The Phase 2b Sadal Study

Marie Maerevoet, MD, Joost Vermaat, MD PhD, Miguel A. Canales, René-Olivier Casasnovas, MD, Eric Van Den Neste, Andre Goy, MD, Brian T. Hill, MD PhD, Catherine Thieblemont, MD PhD, Maria De Fatima De La Cruz, Federica Cavallo, MD PhD, George Follows, MD, Sylvain Choquet, MD, Ronit Gurion, MD, Reda Bouabdallah, MD, Ulrich Jaeger, MD, Agnes Nagy, MD, John Kuruvilla, MD, Krzysztof Warzocha, MD, Nagesh Kalakonda, MD, Paolo Caimi, MD, Sameer Bakhshi, MD, Matthew Ku, MBBS, FRACP, FRCPA, Nada Hamad, MD, Hendrik Veelken, MD PhD, Ewa Matczak, MD, Xiwen Ma, Jean-Richard Saint-Martin, Jatin J. Shah, MD, Michael G. Kauffman, MD PhD, Sharon Shacham, PhD MBA, Josée M Zijlstra, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1677.
https://doi.org/10.1182/blood-2018-99-116868
Published: 2018
Journal Articles

Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, MD PhD, Robert M. Dean, MD, Deepa Jagadeesh, MDMPH, Alex V. Mejia Garcia, MD, Brad Pohlman, MD, Allison M. Winter, MD, Ethan Krauspe, BA, Patrick Collier, MD PhD, Christopher D'Andrea, PA-C, Ashley Morrison, RN, Sarah Lehmann, RN, Benjamin K. Tomlinson, MD, Brenda Cooper, MD, Marcos de Lima, MD, Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Paolo Caimi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1692.
https://doi.org/10.1182/blood-2018-99-113381
Published: 2018
Journal Articles

Chronic Lymphocytic Leukemia (CLL) Transformed into Hodgkin Lymphoma (HL): Clinical Characteristics and Outcomes from a Large Multi-Center Collaboration

Deborah M. Stephens, Ken Boucher, PhD, Elizabeth Kander, MD, Sameer A. Parikh, MD, Erin Parry, MD PhD, Mazyar Shadman, MD MPH, John M. Pagel, MD PhD, Jennifer Cooperrider, BA, Joanna Rhodes, MD, Anthony R. Mato, MDMSCE, Allison M. Winter, MD, Brian T. Hill, MD PhD, Sameh Gaballa, MD, Alexey V Danilov, MD PhD, Tycel J. Phillips, MD, Danielle M. Brander, MD, Sonali M. Smith, MD, Matthew S Davids, Kerry A. Rogers, MD, Martha Glenn, MD, John C. Byrd, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1648.
https://doi.org/10.1182/blood-2018-99-113173
Published: 2018
Journal Articles

Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience

Loretta J. Nastoupil, MD, Michael D. Jain, MDPhD, Jay Y. Spiegel, MD, Armin Ghobadi, MD, Yi Lin, MD PhD, Saurabh Dahiya, MD, Matthew A. Lunning, DO, Lazaros J. Lekakis, MD, Patrick M. Reagan, MD, Olalekan O. Oluwole, MBBS, MPH, Joseph P. McGuirk, DO, Abhinav Deol, MD, Alison R. Sehgal, MD, Andre Goy, MD, Brian T. Hill, MD PhD, Charalambos Andreadis, MD, Javier Munoz, MD, Jason R. Westin, MD, Julio C. Chavez, MD, Amanda F Cashen, MD, Nora N Bennani, MD, Aaron P. Rapoport, MD, Julie M. Vose, MDMBA, David B. Miklos, MD PhD, Sattva S. Neelapu, MD, Frederick L. Locke, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 91.
https://doi.org/10.1182/blood-2018-99-114152
Published: 2018
Journal Articles

Safety and Efficacy of Venetoclax Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide Chemoimmunotherapy (VICER) for Treatment of Relapsed Diffuse Large B Cell Lymphoma: Results from the Phase 1 Study

Paolo Caimi, MD, Deepa Jagadeesh, MDMPH, Kirsten Marie Boughan, DO, Robert M. Dean, MD, Brenda Cooper, MD, Brad Pohlman, MD, Molly M Gallogly, MDPhD, Sarah L. Ondrejka, DO, Erika Moore, MD, Kwadwo Asare Oduro, MDPhD, Eric D. Hsi, MD, Marcos de Lima, MD, Brian T. Hill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 397.
https://doi.org/10.1182/blood-2018-99-115587
Published: 2018
Journal Articles

2-Year Follow-up and High-Risk Subset Analysis of Zuma-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Refractory Large B Cell Lymphoma

Sattva S. Neelapu, MD, Armin Ghobadi, MD, Caron A. Jacobson, MD MMSc, David B. Miklos, MD PhD, Lazaros J. Lekakis, MD, Olalekan O. Oluwole, MBBS, MPH, Yi Lin, MD PhD, Ira Braunschweig, MD, Brian T. Hill, MD PhD, John M. Timmerman, MD, Abhinav Deol, MD, Patrick M. Reagan, MD, Patrick J. Stiff, MD, Ian W. Flinn, MD PhD, Umar Farooq, MD, Andre Goy, MD, Peter A. McSweeney, MD, Javier Munoz, MD, Tanya Siddiqi, MD, Julio C. Chavez, MD, Alex F. Herrera, MD, Allen Xue, PhD, Yizhou Jiang, PhD, Adrian Bot, MD PhD, John M. Rossi, MS, Jenny J. Kim, MD MS, William Y. Go, MD PhD, Frederick L. Locke, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2967.
https://doi.org/10.1182/blood-2018-99-111368
Published: 2018
Journal Articles

Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients

Anthony R. Mato, MD MSCE, Lindsey E. Roeker, MD, Toby A. Eyre, Chadi Nabhan, MD, Nicole Lamanna, MD, Brian T. Hill, MD PhD, Danielle M. Brander, MD, Paul Barr, MD, Frederick Lansigan, MD, Bruce Cheson, MD, Arun K Singavi, MD, Maryam Yazdy, MD, Nirav N Shah, MD, John N. Allan, MD, Erica B Bhavsar, BS, Joanna Rhodes, MD, Kaitlin Kennard, RN, BSN, Stephen J. Schuster, MD, Annalynn M Williams, MS, Alan P Skarbnik, MD, Andre Goy, MD, Catherine C. Coombs, MD, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Ryan Jacobs, MD, Allison M. Winter, MD, John M. Pagel, MD PhD, Neil Bailey, MSc, Anna Schuh, MD PhD, Mazyar Shadman, MD MPH, Andrea Sitlinger, MD, Hanna Weissbrot, BS, Sivraj Muralikrishnan, MD, Amy A Kirkwood, MSc, Christopher P. Fox, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3142.
https://doi.org/10.1182/blood-2018-99-114840
Published: 2018
Journal Articles

Early Infectious Complications after Autologous Hematopoietic Cell Transplantation (AHCT) for Lymphoma

Shafia Rahman, MD, Lisa Rybicki, MS, Eric Cober, MD, Robert M. Dean, MD, Betty K. Hamilton, MD, Deepa Jagadeesh, MD MPH, Brian T. Hill, MD PhD, Brad Pohlman, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Sherif Mossad, MD, Navneet S. Majhail, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4755.
https://doi.org/10.1182/blood-2018-99-117758
Published: 2018
Journal Articles

Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study

Anthony R Mato, MD, Maryam Sarraf Yazdy, MD, Brian T. Hill, MD PhD, Mazyar Shadman, Hande Tuncer, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, John N. Allan, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Chadi Nabhan, MD, Paul Barr, MD, Jennifer R. Brown, MD PhD, Christopher P. Fox, MD PhD, Joanna Rhodes, MD, Anna Schuh, MD PhD, Toby A. Eyre, MD, Nicole Lamanna, MD, Nitin Jain, MD, William G. Wierda, MD PhD, Alan P Skarbnik, MD, Lindsey E. Roeker, MD, Rajat Bannerji, MD PhD, Andrew M. Evens, MD, Frederick Lansigan, MD, Jennifer C. Samp, MS, PharmD, Jacqueline Nielsen, PhD, James M. Pauff, Thomas J. Kipps, MD PhD, Stephen J. Schuster, MD, George A Follows, MD PhD, Bruce Cheson, MD, Barbara Eichhorst
Journal: Blood
Blood (2018) 132 (Supplement 1): 4759.
https://doi.org/10.1182/blood-2018-99-119015
Published: 2018
Journal Articles

Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

James Nathan Gerson, MD, Stefan Klaus Barta, MDMRCP,MS, Diego Villa, Alina S Gerrie, MD, Shaoying Li, MD, Jeffrey Medeiros, MD, Michael Wang, MD, Brian T. Hill, MD PhD, Yazeed Sawalha, MD, Francisco J. Hernandez-Ilizaliturri, MD, Shalin Kothari, MD, Julie M Vose, MD, Timothy S. Fenske, MD, Swapna Narayana Rao, MD, Kami J. Maddocks, MD, David A Bond, MD, Frederick Lansigan, MD, Timothy Burns, MD, Alexandra M Donovan, MD, Amitkumar Mehta, MD, Nishitha Reddy, MD MSCI, MBBS, Daniel J. Landsburg, MD, Martha Glenn, MD, David James Inwards, MD, Kay Ristow, Reem Karmali, MD MS, Jason Kaplan, MD, Elvira Umyarova, MD, Bhargavi Pulluri, MD, Jennifer E Amengual, MD, Jennifer Kimberly Lue, MD, Paolo Caimi, MD, Jonathon B Cohen, MDMS, Oscar Calzada, BS, Elizabeth Handorf, Jennifer Kelly Anderson, MD, Parv Chapani, Veronika Bachanova, MD PhD, Saurabh Rajguru, MD, Michael C Churnetski, BS, Catherine Diefenbach, Martin Bast, Alexandra E. Kovach, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 341.
https://doi.org/10.1182/blood.V130.Suppl_1.341.341
Published: 2017
Journal Articles

Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT)

Jessica ElAsmar, MD, Lisa Rybicki, MS, Brian J. Bolwell, MD, Mohamed A Kharfan-Dabaja, MD, Robert M. Dean, MD, Betty K. Hamilton, MD, Rabi Hanna, MD, Deepa Jagadeesh, MDMPH, Matt Kalaycio, MD, Hien D. Liu, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Brian T. Hill, MD PhD, Navneet S. Majhail, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 3437.
https://doi.org/10.1182/blood.V130.Suppl_1.3437.3437
Published: 2017
Journal Articles

The Role of Upfront Autologous Hematopoietic Cell Transplantation in the Treatment of Mantle Cell Lymphoma, a Population Based Study Using the National Cancer Data Base (NCDB)

Yazeed Sawalha, MD, Tomas Radivoyevitch, Katherine Tullio, Robert M. Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD PhD, Matt Kalaycio, MD, Navneet S. Majhail, MD MS, Deepa Jagadeesh, MDMPH
Journal: Blood
Blood (2017) 130 (Supplement 1): 2009.
https://doi.org/10.1182/blood.V130.Suppl_1.2009.2009
Published: 2017